A data base of clinical studies is required for quality assurance of software used for analysis of radionuclide cardiac imaging procedures. Studies used must be rigorously validated in terms of both the clinical condition of the patient undergoing the procedure and the imaging protocol used. Selection protocols for the creation of a software phantom data base of normal studies and three typical patterns of cardiac disease — recent transmural myocardial infarction, isolated myocardial ischaemia and dilated cardiomyopathy — have been developed by the Cardiac Working Group of the European COST B2 project in association with the Cardiac Task Group of the European Association of Nuclear Medicine and the Working Group on Nuclear Cardiology of the European Society of Cardiology. These protocols include criteria for the interpretation of qualitative and quantitative non-radionuclide data. Compliance of the clinical data with the selection criteria will have to pass scrutiny by an international team for each study used as a software phantom. The radionuclide studies encompass stress and rest myocardial perfusion studies (planar and single photon emission tomography) using thallium-201 and technetium-99m methoxyisobutylisonitrile and rest gated blood pool studies. Methods for acquisition of data are defined for each type of study and for each individual study a portfolio of all clinical data is established. A pilot study is required to investigate the problems and logistics of distributing clinical radionuclide studies between a range of computers and institutes, and to ascertain the procedures necessary for analytical comparison of the results obtained.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Britton KE, Busemann Sokole E (1990) Quality assurance in nuclear medicine software and ‘COST’. Nucl Med Commun 11:334–338
Britton KE, Busemann Sokole E (1992) COST B2: why and wherefore. Eur J Nucl Med 19:563–568
Busemann Sokole E, Cradduck TD, Erickson JJ (1990) Experience with gated cardiac software phantoms for quality control of applications programmes. Eur J Nucl Med 17:106–110
Diamond GA, Forrester JS (1979) Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 300:1350–1358
Erickson JJ, Price RR, Touja JJ, Krononberg MW, Peterson R, Rollo FD (1981) Quality control of software in dissimilar systems using a common clinical data base. In: Medical radionuclide imaging, vol 11. International Atomic Energy Agency, Vienna, pp 47–55
New York Heart Association — The Criteria Committee of the New York Heart Association (1964) Diseases of the heart and blood vessels; nomenclature and criteria for diagnosis, 6th edn. Little, Brown and Co, Boston
Sahn DJ, DeMaria A, Kissio J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083
Sandler H, Dodge HT (1974) Angiographic methods for determination of left ventricular geometry and volume. In: Mirsky I, Ghista DN, Sadler D (eds) Cardiac mechanics: physiological, clinical and mathematical considerations. John Wiley, New York
Sheehan FH, Dodge HT, Mathey DG, Brown BG, Bolson EL, Mitten S (1982) Application of the centerline method: analysis of change in regional left ventricular motion in serial studies. IEEE Comput Cardiol: p 9
World Health Organisation (1978) Arterial hypertension. Technical Report Series number 628
About this article
Cite this article
Bourguignon, M.H., Busemann Sokole, E., Jones, B. et al. Protocols for selection of cardiac radionuclide studies for use as a data base of normal studies and typical patterns of diseases. Eur J Nucl Med 20, 59–65 (1993). https://doi.org/10.1007/BF02261247
- Radionuclide imaging
- Quality assurance
- Data base